- Home
- HIND vs QNME Comparison
HIND vs QNME Comparison
Compare HIND & QNME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HIND | QNME |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | 2 | N/A |
| Industry | | Integrated Freight & Logistics |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2M | 16.2M |
| IPO Year | 2016 | 2024 |
Fundamental Metrics
Financial Performance| Metric | HIND | QNME |
|---|---|---|
| Price | $2.22 | $0.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 7.4K | ★ 436.2K |
| Earning Date | 05-20-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 64.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $319,714.00 | ★ $18,315,155.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 24.43 | ★ 42.28 |
| 52 Week Low | $1.75 | $0.30 |
| 52 Week High | $9.69 | $0.59 |
Technical Indicators
Market Signals| Indicator | HIND | QNME |
|---|---|---|
| Relative Strength Index (RSI) | 46.22 | N/A |
| Support Level | $1.99 | N/A |
| Resistance Level | $2.35 | N/A |
| Average True Range (ATR) | 0.11 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 46.03 | 0.00 |
Price Performance
Historical ComparisonAbout HIND Vyome Holdings Inc.
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
About QNME Quanome Technologies Inc. Common Stock
Quanome Technologies Inc is a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea.